Investment Highlights

  • CVS operates in a vibrant industry with highly favorable long-term trends.

  • CVS has a motivated and experienced management team.

  • CVS is a well-positioned leader and has demonstrated industry-leading growth and productivity.

  • CVS is #1 in store count, scripts filled and RX sales.  We dispensed a record 281 million prescriptions in 1999 or approximately 13% of all prescriptions.

  • CVS is a key competitor on the Internet. The June, 1999 aquisition of Soma.com, and subsequent re-launch as CVS.com provides us with a platform to reach new customers and expand CVS as a national pharmacy brand. It is an integral part of our strategy to provide total healthcare solutions to our customers.

  • CVS is #1 in 30 of the top 100 U.S. Drugstore markets, more than any other chain.

  • CVS has numerous growth opportunities:
    • CVS will continue to drive its core business by focusing on higher margin, destination categories such as photofinishing, cosmetics, greeting cards, seasonal and general merchandise.
    • The company will also implement several key technology initiatives that will continue to improve service and decrease costs.
    • CVS opened a record 433 new or relocated CVS/Pharmacy and 12 ProCare stores in 1999. In 2000, we expect to continue our aggressive growth program with the opening of approximately 400-450 new or relocated stores.
    • CVS has upside potential from the Revco and Arbor Drug acquisitions, completed in 1997 and 1998 respectively.
    • CVS has innovative healthcare initiatives and is well-positioned to take advantage of the changing world of healthcare.

  • CVS' balance sheet is healthy, with a debt to total capitalization ratio of approximately 21.8% (as of January 1, 2000).

  • In 1999, CVS aggressively launched our specialty pharmacy business, CVS ProCare, and we already have a strong foothold in this $14 billion fast-growing segment of the pharmacy market.